Summary
In four of the five autosomal dominant porphyrias four different partial enzymatic defects of the porphyrin biosynthetic pathway have been discovered in the last few years. With the exception of protoporphyria, the residual enzymatic activity in carriers of these defects is approximately equal to 50% of that found in controls. In each case the pattern of excretion of porphyrin and/or porphyrin precursors reflects the site of the partial metabolic block. There are indications, at least in intermittent acute porphyria, that the degree of penetrance of the disorder varies according to the level of phenotypic expression, being highest for the enzyme deficiency, lower for the excretion of precursors and lowest for the clinical symptoms. It is proposed that environmental factors, and probably also gene interaction, are the cause of the different degrees of penetrance.
Similar content being viewed by others
References
Bonkowsky, H. L., Bloomer, J. R., Mahoney, M. J., Ebert, P. S.: Demonstration of deficient heme synthetase activity in human protoporphyria. Clin. Res. 23, 261A (1975)
Bonkowsky, H. L., Tschudy, D. P., Collins, A., Doherty, J., Bossenmaier, I., Cardinal, R., Watson, C. J.: Repression of the overproduction of porphyrin precursors in IAP by intravenous infusion of hematin. Proc. Natl. Acad. Sci. U.S.A. 68, 2725–2729 (1971)
Bottomley, S. S., Tanaka, M., Everett, M. A.: Diminished erythroid ferrochelatase activity in PP. J. Lab. Clin. Med. 86, 126–131 (1975)
Bradlow, H. L., Anderson, K., Kappas, A.: Differences between cutaneous and hepatic steroid 5-a-reductase in patients with IAP. In: Porphyrins in human diseases, M. Doss, ed., pp. 173–178. Basel: Karger 1976
Brodie, M. J., Thompson, G. G., Moore, M. R., Beattie, A. D., Goldberg, A.: Hereditary coporphyria. Q. J. Med. (in press, 1977)
Correia, M. A., Meyer, U. A.: Apocytochrome P450: reconstruction of functional cytochrome with hemin in vitro. Proc. Natl. Acad. Sci. U.S.A. 72, 400–404 (1975)
Dean, G.: The porphyrias. A story of inheritance and environment. Philadelphia: Lippincott 1971
Eales, L.: Acute porphyria: the precipitating and aggravating factors. S. Afr. J. Lab. Clin. Med. 17, 120–126 (1971)
Elder, G. H., Evans, J. O., Thomas, N., Cox, R., Brodie, M. J., Moore, M. R., Goldberg, A., Nicholson, D. C.: The primary enzyme defect in HC. Lancet 1976II, 1217–1219
Goldberg, A., Rimington, C., Lochhead, A. C.: Hereditary coproporphyria. Lancet 1967I, 632–636
Goldstein, J. L., Brown, M. S.: Familial hypercholesterolemia: a genetic regulatory defect in cholesterol metabolism. Am. J. Med. 58, 147–150 (1975)
Grandchamp, B., Nordman, Y.: Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria. Biochem. Biophys. Res. Commun. 74, 1089–1095 (1977)
Heilmeyer, L., Clotten, R.: Die kongenitale erythropoetische Coproporphyrie. Eine dritte erythropoetische Porphyrieform. Dtsch. Med. Wochenschr. 89, 669 (1964)
Hofstad, F., Seip, M., Eriksen, L.: CEP with a hitherto undescribed porphyrin pattern. Acta Paediatr. Scand. 62, 380–384 (1973)
Kaneko, J. J., Mills, R. A.: Hematological and blood chemical observations in neonatal normal and porphyric calves in early life. Cornell Vet. 60, 52–60 (1970)
Kaufman, L., Marver, H. S.: Biochemical defects in two types of human hepatic porphyria. N. Engl. J. Med. 283, 954–958 (1970)
Kaufman, L., Marver, H. S.: Biochemical defects in two types of human hepatic porphyria. N. Engl. J. Med. 283, 954–958 (1970)
Kordaç, V., Papežová, R., Semrádová, M.: Chloroquine in the treatment of PCT. N. Engl. J. Med. 296, 949 (1977)
Kowertz, M. J.: Hepatocutaneous recovery in PCT. In: Porphyrins in human diseases, M. Doss, ed., pp. 356–360. Basel: Karger 1976
Kramer, S., Viljoen, E., Meyer, A. M., Metz, J.: The anaemia of CEP with the first description of the disease in an elderly patient. Br. J. Haematol. 11, 666–675 (1965)
Kreimer-Birnbaum, M., Tomio, M. J.: Studies on uroporphyrinogen synthetase from human erythrocytes. In: Porphyrins in human diseases, M. Doss, ed., pp. 182–188. Basel: Karger 1976
Kushner, J. P., Steinmuller, D. P., Lee, G. R.: The role of iron in the pathogenesis of PCT: inhibition of uroporphyrinogen decarboxylase. J. Clin. Invest. 56, 661–667 (1975)
Kushner, J. P., Barbuto, A. J., Lee, R. G.: An inherited enzymatic defect in PCT: decreased uroporphyrinogen decarboxylase activity. J. Clin. Invest. 58, 1089–1097 (1976)
Lascelles, J.: Tetrapyrrole biosynthesis and its regulation. New York: Benjamin 1966
Levin, E. Y.: Comparative aspects of porphyria in man and animals. Ann. N.Y. Acad. Sci. 244, 481–495 (1975)
Loots, J. M., Becker, D. M., Meyer, B. J., Goldstuck, N., Kramer, S.: The effect of porphyrin precursors on monosynaptic reflex activity in the isolated hemisected frog spinal cord. J. Neurol. Transm. 36, 71–81 (1975)
Magnus, I. A.: Dermatological photobiology: clinical and experimental aspects. Oxford: Blackwell 1976
Magnus, I. A., Jarret, A., Pankerd, T. A., Rimington, C.: Erythropoietic protoporphyria: a new porphyria syndrome with solar uticaria due to protoporphyrinemia. Lancet 1961II, 448–451
Marver, H. S., Schmid, R.: The porphyrias. In: The metabolic basis of inherited disease, 3rd ed., J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds., pp.1124–1126. New York: McGraw-Hill 1972
Meyer, U. A.: Intermittent acute porphyria. Enzyme 16, 334–347 (1973)
Meyer, U. A.: Hepatic porphyrias: new findings on the nature of metabolic defects. Prog. Liver Dis. 5, 280–295 (1976)
Meyer, U. A., Schmid, R.: The porphyrias. In: The metabolic basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrickson, eds. New York: McGraw-Hill (in press, 1977)
Meyer, U. A., Strand, L. J., Doss, M., Clegg Rees, A., Marver, H. S.: IAP: demonstration of a genetic defect in PBG metabolism. N. Engl. J. Med. 286, 1277–1282 (1972)
Miyagi, K., Cardinal, R., Bossenmaier, I., Watson, C. J.: The serum PBG and hepatic PBG deaminase in normal and porphyric individuals. J. Lab. Clin. Med. 78, 683–695 (1971)
Miyagi, K., Petryka, J., Bossenmaier, I., Cardinal, R., Watson, C. J.: The activities of uroporphyrinogen synthetase and cosynthetase in CEP. Am. J. Hematol. 1, 3–21 (1976)
Mustagoki, P., Koskelo, P.: Hereditary hepatic porphyrias in Finland. Acta Med. Scand. 200, 171–198 (1976)
Nacht, S. L. C., San Martin de Viale, Grinstein, M.: Human PCT. Isolation and properties of urinary porphyrins. Clin. Chim. Acta 27, 445–452 (1970)
Pain, R. W., Welch, F. W., Woodroffe, A. J., Handley, D. A., Lockwood, W. H.: Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studies. Br. Med. J. 3, 621–623 (1975)
Petryka, Z. J.: In the discussion following Levin's paper. Ann. N.Y. Acad. Sci. 244, 493–495 (1975)
Reed, W. B., Wuepper, K. D., Epstein, J. H., Redeker, A., Simonson, R. I., McKusick, V. A.: Erythropoietic protoporphyria. A clinical and genetic study. JAMA 214, 1060–1066 (1970)
Romeo, G., Glenn, B. L., Levin, E. Y.: Uroporphyrinogen-III-cosynthetase in asymptomatic carriers of CEP. Biochem. Genet. 4, 719–726 (1970b)
Romeo, G., Kaback, M. M., Levin, E. Y.: Uroporphyrinogen-III-cosynthetase activity in fibroblasts from patients with CEP. Biochem. Genet. 4, 659–664 (1970a)
Romeo, G., Levin, E. Y.: Uroporphyrinogen-III-cosynthetase in human congenital erythropoietic porphyria. Proc. Natl. Acad. Sci. U.S.A. 63, 856–863 (1969)
Romeo, G., Levin, E. Y.: Uroporphyrinogen decarboxylase from mouse spleen. Biochem. Biophys. Acta 230, 330–341 (1971)
Sassa, S., Granick, S., Bickers, D. R., Bradlow, H. L., Kappas, A.: A microassay for uroporphyrinogen-I-synthetase, one of three abnormal enzyme activities in AIP, and its application to the study of the genetics of the disease. Proc. Natl. Acad. Sci. U.S.A. 71, 732–736 (1974)
Sassa, S., Granick, S., Bickers, D. R., Levere, R. D., Kappas, A.: Studies on inheritance of human erythrocyte ALA dehydratase and uroporphyrinogen synthetase. Enzyme 16, 326–333 (1973)
Sassa, S., Solish, G., Levere, R. D., Kappas, A.: IV. Expression of the gene defect of IAP in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait. J. Exp. Med. 142, 722–731 (1975)
Schwartz, S., Johnson, J. A., Stephenson, B. D., Anderson, A. S., Edmonson, P. R., Fusaro, R. M.: Erythropoietic defects in PP: a study of factors involved in labeling of porphyrins and bile pigments from ALA-3H and glycine-14C. J. Lab. Clin. Med. 78, 411–434 (1971)
Schmidt, H., Snitker, G., Thomsen, K., Lintrup, J.: Erythropoietic protoporphyria. Arch. Dermatol. 110, 58–64 (1974)
Strand, J. L., Felsher, B. F., Redeker, A. G., Marver, H. S.: Heme biosynthesis in IAP: decreased hepatic conversion of PBG to porphyrins and increased ALA-synthetase activity. Proc. Natl. Acad. Sci. U.S.A. 67, 1315–1320 (1970)
Strand, J. L., Manning, J., Marver, H. S.: The induction of ALA-synthetase in cultured liver cells. J. Biol. Chem. 247, 2820–2827 (1972a)
Strand, L. J., Meyer, U. A., Felsher, B. F., Redeker, A. G., Marver, H. S.: Decreased RBC uroporphyrinogen-I-synthetase in IAP. J. Clin. Invest. 51, 2530–2536 (1972b)
Tschudy, D. P., Bonkowsky, H. L.: A steady state model of sequential irreversible reactions. Mol. Cell. Biochem. 2, 55–62 (1973)
Walderström, J.: The porphyrias as inborn errors of metabolism. Am. J. Med. 22, 759–773 (1957)
Watson, C. J., Pierach, C. A., Bossenmeier, I., Cardinal, R.: Postulated deficiency of hepatic heme and repair by hematin infusions in the ‘inducible’ hepatic porphyrias. Proc. Natl. Acad. Sci. U.S.A. 74, 2118–2120 (1977)
Watson, C. J., Taddeini, L., Bossenmeier, I.: Present status of the Erlich aldehyde reaction for urinary PBG. JAMA 190, 501–504 (1964b)
Watson, C. J., Runge, W., Taddeini, L., Bossenmeier, I., Cardinal, R.: A suggested control gene mechanism for the excessive production of types I and III porphyrins in CEP. Proc. Natl. Acad. Sci. U.S.A. 52, 478–485 (1964a)
Wetterberg, L.: A neuropsychiatric and genetical investigation of IAP. Svenska Bokförlaget: Horsteds 1967
With, T. K.: Screening test for acute porphyria. Lancet 1970II, 1187–1188
Author information
Authors and Affiliations
Additional information
On leave from the University of Naples, Italy
Rights and permissions
About this article
Cite this article
Romeo, G. Analytical review enzymatic defects of hereditary porphyrias: An explanation of dominance at the molecular level. Hum Genet 39, 261–276 (1977). https://doi.org/10.1007/BF00295419
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00295419